NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Monitoring whole blood sirolimus concentration during therapy, particularly in individuals coadministered CYP3A4 substrates, inhibitors, or inducers
Adjusting dose to optimize immunosuppression while minimizing toxicity
Evaluating patient compliance
High-Performance Liquid Chromatography-Tandem Mass Spectrometry (HPLC-MS/MS)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name